Osteonecrosis of the Jaw Associated With Bevacizumab in Treatment: A Case Series Using the FDA Adverse Event Reporting System (FAERS) Database

被引：0
|
作者：
Ahdi, Hardeep S. [1 ]
Wichelmann, Thomas A. [2 ]
Pandravada, Sasirekha [2 ]
Ehrenpreis, Eli [3 ]
机构：
[1] Advocate Lutheran Gen Hosp, Chicago, IL USA
[2] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
[3] Advocate Lutheran Gen, Evanston, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S166
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [31] Assessing taxane-associated adverse events using the FDA adverse event reporting system database
    Lao, Dong-Hui
    Chen, Ye
    Fan, Jun
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (12) : 1471 - 1476
  • [32] A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)
    Zou, Wenbin
    Yang, Han
    Xi, Yu
    Zeng, Chenxi
    Chen, Wei
    Fu, Xiangning
    HELIYON, 2024, 10 (17)
  • [33] Investigating the Accuracy of the openFDA API using the FDA Adverse Event Reporting System (FAERS)
    Shin, Jennifer
    2014 IEEE INTERNATIONAL CONFERENCE ON BIG DATA (BIG DATA), 2014,
  • [34] Analysis of literature-derived duplicate records in the FDA Adverse Event Reporting System (FAERS) database
    Han, Weiru
    Morris, Robert
    Bu, Kun
    Zhu, Tianrui
    Huang, Hong
    Cheng, Feng
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2025, 103 (02) : 56 - 69
  • [35] A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
    Liu, Liyuan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [36] Bleeding related adverse events associated with antiviral treatment in influenza patients: A disproportionality analysis using FDA adverse event reporting system (FAERS)
    Sarker, Jyotirmoy
    Carkovic, Emir
    Lee, Todd A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 486 - 487
  • [37] Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)
    Stamoula, Eleni
    Stamatellos, Vasileios-Periklis
    Vavilis, Theofanis
    Dardalas, Ioannis
    Papazisis, Georgios
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (02) : 239 - 245
  • [38] A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database
    Yang, Haiyan
    Wan, Zheng
    Chen, Moliang
    Zhang, Xiaohong
    Cui, Wugeng
    Zhao, Bin
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (04) : 217 - 223
  • [39] A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
    Zou, Fan
    Zhu, Chengyu
    Lou, Siyu
    Cui, Zhiwei
    Wang, Dan
    Ou, Yingyong
    Wang, Li
    Chen, Junyou
    Lan, Yuanbo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Sun, Ximu
    Zhou, Han
    Li, Yanming
    Luo, Yanhui
    Guo, Qixiang
    Sun, Yixin
    Jia, Chenguang
    Wang, Bin
    Qin, Maoquan
    Guo, Peng
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 11 (01)
12345